Non-Alcoholic Fatty Liver Disease | Zendy

HuiHui Tan | Zendy; Jason PikEu Chang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Non-Alcoholic Fatty Liver Disease

Author(s) -

HuiHui Tan,

Jason PikEu Chang

Publication year - 2010

Publication title -

proceedings of singapore healthcare

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

eISSN - 2059-2329

pISSN - 2010-1058

DOI - 10.1177/201010581001900106

Subject(s) - steatohepatitis , fatty liver , cirrhosis , steatosis , medicine , liver biopsy , gastroenterology , metabolic syndrome , alcoholic liver disease , gold standard (test) , disease , biopsy , obesity

Non-alcoholic fatty liver disease (NAFLD) comprises a disease spectrum ranging from benign hepatic steatosis to non-alcoholic steatohepatitis with inflammation (NASH) and liver cirrhosis. NAFLD is now recognised as the hepatic manifestation of the metabolic syndrome. Simple steatosis is benign, whereas NASH can progress to cirrhosis with its resultant complications. Liver biopsy remains the gold standard in the diagnosis of NAFLD/NASH. Lifestyle and dietary modifications to achieve sustained weight loss is the cornerstone of NAFLD/NASH treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research